A comparison of three smokeless tobacco dependence measures

Addictive Behaviors

Volumn 37, Issue 11, 2012, Pages 1271-1277

  Ebbert, Jon O ^b   Severson, Herbert H ^a   Danaher, Brian G ^a   Schroeder, Darrell R ^b   Glover, Elbert D ^c  

^a OREGON RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Dependence measure; FTQ ST; GN STBQ; Nicotine; Smokeless tobacco; SSTDS; ST; Tobacco use disorder

Indexed keywords

AMFEBUTAMONE; COTININE; NICOTINE; PLACEBO;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SMOKELESS TOBACCO; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ADULT; AGED; BUPROPION; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUESTIONNAIRES; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TOBACCO, SMOKELESS; YOUNG ADULT;

EID: 84864001769     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2012.06.011     Document Type: Article

References (45)

1. Akers L., Severson H.H., Yovanoff P., Boles S.M. Using item response theory to develop models of smokeless tobacco dependence 2011, Oregon Research Institute, Eugene, OR. Oregon Research Institute Tobacco Workgroup Technical Report 2011 (Ed.).
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington, DC. 4th edition.
3. Borrell-Carrio F., Suchman A.L., Epstein R.M. The biopsychosocial model 25years later: Principles, practice, and scientific inquiry. Annals of Family Medicine 2004, 2:576-582. 10.1370/afm.245.
4. Boyle R.G., Jensen J., Hatsukami D.K., Severson H.H. Measuring dependence in smokeless tobacco users. Addictive Behaviors 1995, 20:443-450. 10.1016/0306-4603(95)00013-3.
5. Campaign for Tobacco Free Kids R.J. Reynolds entry into smokeless tobacco market cause for major concern Retrieved from, [April 28]. http://www.tobaccofreekids.org/Script/DisplayPressRelease.php3?Display=911.
6. Colby S.M., Tiffany S.T., Shiffman S., Niaura R.S. Measuring nicotine dependence among youth: a review of available approaches and instruments. Drug and Alcohol Dependence 2000, 59(Suppl. 1):S23-S39. 10.1016/S0376-8716(99)00163-5.
7. Critchley J.A., Unal B. Health effects associated with smokeless tobacco: a systematic review. Thorax 2003, 58:435-443. 10.1136/thorax.58.5.435.
8. Dale L.C., Ebbert J.O., Glover E.D., Croghan I.T., Schroeder D.R., Severson H.H., et al. Bupropion SR for the treatment of smokeless tobacco use. Drug and Alcohol Dependence 2007, 90:56-63. 10.1016/j.drugalcdep. 2007.02.008.
9. DiFranza J.R., Sweet M., Savageau J.A., Ursprung W.W. The assessment of tobacco dependence in young users of smokeless tobacco. Tobacco Control 2011, Jun 28. [Epub ahead of print]. 10.1136/tc.2011.043810.
10. Djordjevic M.V., Hoffman D., Glynn T., Connolly G.N. U.S. Commercial Brands of Moist Snuff, 1994. I. Assessment of nicotine, moisture, and pH. Tobacco Control 1995, 4:62-66.
11. Ebbert J.O., Patten C.A., Schroeder D.R. The Fagerstrom test for nicotine dependence-smokeless tobacco (FTND-ST). Addictive Behaviors 2006, 31:1716-1721. 10.1016/j.addbeh.2005.12.015.
12. Embretson S.E., Reise S.P. Item response theory for psychologists 2000, Lawrence Erlbaum Associates, Mahwah, NJ.
13. Etter J.F., Duc T.V., Perneger T.V. Validity of the Fagerstrom test for nicotine dependence and of the heaviness of smoking index among relatively light smokers. Addiction 1999, 94:269-281. 10.1046/j.1360-0443.1999.94226910.x.
14. Etter J.F., Le Houezec J., Perneger T.V. A self-administered questionnaire to measure dependence on cigarettes: the cigarette dependence scale. Neuropsychopharmacology 2003, 28:359-370. 10.1038/sj.npp. 1300030.
15. Fagerström K.O., Schneider N.G. Measuring nicotine dependence: a review of the Fagerstrom tolerance questionnaire. Journal of Behavioral Medicine 1989, 12:159-182.
16. Glover E.D., Nilsson F., Westin A., Glover P.N., Laflin M.T., Persson B. Developmental history of the Glover-Nilsson smoking behavioral questionnaire. American Journal of Health Behavior 2005, 29:443-455.
17. Goodman M.T., Morgenstern H., Wynder E.L. A case-control study of factors affecting the development of renal cell cancer. American Journal of Epidemiology 1986, 124:926-941.
18. Haddock C.K., Lando H., Klesges R.C., Talcott G.W., Renaud E.A. A study of the psychometric and predictive properties of the Fagerstrom test for nicotine dependence in a population of young smokers. Nicotine & Tobacco Research 1999, 1:59-66.
19. Heatherton T.F., Kozlowski L.T., Frecker R.C., Rickert W., Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. British Journal of Addiction 1989, 84:791-799.
20. Henley S.J., Thun M.J., Connell C., Calle E.E. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes and Control 2005, 16:347-358. 10.1007/s10552-004-5519-6.
21. Hudmon K.S., Marks J.L., Pomerleau C.S., Bolt D.M., Brigham J., Swan G.E. A multidimensional model for characterizing tobacco dependence. Nicotine & Tobacco Research 2003, 5:655-664.
22. Hughes J.R. Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine & Tobacco Research 2007, 9:315-327.
23. Hughes J.R. Minnesota nicotine withdrawal scale Revised Retrieved from. http://www.uvm.edu/~hbpl/?Page=minnesota/default.html.
24. Hughes J.R., Hatsukami D.K. Errors in using tobacco withdrawal scale. Tobacco Control 1998, 7:92-93. 10.1136/tc.7.1.92a.
25. Kawakami N., Takatsuka N., Inaba S., Shimizu H. Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. Addictive Behaviors 1999, 24:155-166. 10.1016/S0306-4603(98)00127-0 |.
26. Kozlowski L.T., Porter C.Q., Orleans C.T., Pope M.A., Heatherton T. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug and Alcohol Dependence 1994, 34:211-216.
27. Lichtenstein E., Mermelstein R.J. Some methodological cautions in the use of the tolerance questionnaire. Addictive Behaviors 1986, 11:439-442.
28. Lord F.N., Novick M.R. Statistical theories of mental test scores 1968, Reading, MA, Addison-Wesley.
29. McNeill A. Harm reduction. BMJ 2004, 328:885-887. 10.1136/bmj.328.7444.885.
30. Moyer T.P., Charlson J.R., Enger R.J., Dale L.C., Ebbert J.O., Schroeder D.R., et al. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clinical Chemistry 2002, 48:1460-1471.
31. Muscat J.E., Hoffmann D., Wynder E.L. The epidemiology of renal cell carcinoma. A second look. Cancer 1995, 75:2552-2557. 10.1002/1097-0142(19950515.
32. Muscat J.E., Stellman S.D., Hoffmann D., Wynder E.L. Smoking and pancreatic cancer in men and women. Cancer Epidemiology, Biomarkers and Prevention 1997, 6:15-19. 10.1158/1055-9965.EPI-03-0033.
33. NIH State-of-the-Science Panel National Institutes of Health State-of-the-Science conference statement: tobacco use: prevention, cessation, and control. Annals of Internal Medicine 2006, 145:839-844.
34. Pinto R.P., Abrams D.B., Monti P.M., Jacobus S.I. Nicotine dependence and likelihood of quitting smoking. Addictive Behaviors 1987, 12:371-374.
35. Pomerleau C.S., Carton S.M., Lutzke M.L., Flessland K.A., Pomerleau O.F. Reliability of the Fagerström tolerance questionnaire and the Fagerström test for nicotine dependence. Addictive Behaviors 1994, 19:33-39.
36. Reise S.P., Waller N.G., Comrey A.L. Factor analysis and scale revision. Psychological Assessment 2000, 12:287-297.
37. Robins L.N., Cottler L.B., Bucholz K.K., Compton W.M., North C.S., Rourke K.M. NIMH diagnostic interview schedule, version IV 1999, St. Louis, MO, Washington University.
38. Severson H.H., Akers L., Andrews J.A., Boles S.M. Development of a smokeless tobacco dependence scale. Paper presented at the World Conference on Tobacco or Health, Helsinki, Finland 2003.
39. Severson H.H., Andrews J.A., Lichtenstein E., Danaher B.G., Akers L. Self-help cessation programs for smokeless tobacco users: Long-term follow-up of a randomized trial. Nicotine & Tobacco Research 2007, 9:281-289.
40. Severson H.H., Andrews J.A., Lichtenstein E., Gordon J.S., Barckley M., Akers L. A self-help cessation program for smokeless tobacco users: Comparison of two interventions. Nicotine & Tobacco Research 2000, 2:363-370.
41. Shiffman S., Waters A., Hickcox M. The nicotine dependence syndrome scale: A multidimensional measure of nicotine dependence. Nicotine & Tobacco Research 2004, 6:327-348. 10.1080/1462220042000202481.
42. Smith S.S., Piper M.E., Bolt D.M., Fiore M.C., Wetter D.W., Cinciripini P.M., et al. Development of the brief Wisconsin inventory of smoking dependence motives. Nicotine & Tobacco Research 2010, 12:489-499. 10.1093/ntr/ntq032.
43. Stockwell H.G., Lyman G.H. Impact of smoking and smokeless tobacco on the risk of cancer of the head and neck. Head and Neck Surgery 1986, 9:104-110. 10.1002/hed.2890090206.
44. Substance Abuse and Health Services Administration Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of national findings Retrieved from. http://oas.samhsa.gov/NSDUH/2k9NSDUH/2k9Results.htm#Ch4.
45. Thomas J.L., Ebbert J.O., Patten C.A., Dale L.C., Bronars C.A., Schroeder D.R. Measuring nicotine dependence among smokeless tobacco users. Addictive Behaviors 2006, 31:1511-1521. 10.1016/j.addbeh.2005.11.005.